slides · global inventory
01 Logic Chain
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 9,549
Current window 6,601-6,630
Pages 319
Rows per page 30
Loop
6,601-6,630 of 9,549
03
The slide uses a vertical bracket to group three key pillars under the umbrella of 'GENETICS'.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Loop · Logic Chain1 hit
04
The slide uses a circular hub-and-spoke diagram centered on 'Patients' to connect three core pillars: Need, Speed, and Power.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Logic Chain1 hit
05
23andMe | Investor Presentation Deck | 39 slides23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Logic Chain1 hit
06
The slide highlights the competitive advantage of scale and recontactability, supported by a callout on consent rates and a metric on drug success probability.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Logic Chain1 hit
07
The slide highlights the scale of 23andMe's proprietary data by listing specific case counts for various oncology and immune conditions.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Logic Chain1 hit
08
The slide uses a '2x-3x' metric to justify the value of genetic support in drug discovery, citing Nelson et al. (2015) and King et al. (2019).23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Logic Chain1 hit
09
Includes a Manhattan plot visualization and a zoomed-in regional association plot.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Logic Chain1 hit
10
The chart is a dot plot showing odds ratios for various phenotypes related to TSLP.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Logic Chain1 hit
11
The slide demonstrates how 23andMe's genetic data can rescue or refine clinical trial results by identifying biomarkers that stratify patient response.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Logic Chain1 hit
12
The slide uses a process flow diagram to explain the 'POWER' methodology.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Logic Chain1 hit
04
The slide uses a horizontal layout to segment the business into five pillars, each with specific growth drivers and outlooks.AstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Early StrugglesLoop · Logic Chain1 hit
05
The right-hand side is a complex matrix mapping clinical trials to patient segments (HER2-positive, HR-positive, TNBC, gBRCAm) and treatment stages (Neoadjuvant, Adjuvant, Metastatic).AstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Early StrugglesLoop · Logic Chain1 hit
06
The slide uses a structured grid to map corporate acquisitions/partnerships to strategic goals and therapeutic areas.AstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Early StrugglesLoop · Logic Chain1 hit
07
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Rising SuccessLoop · Logic Chain1 hit
08
The slide uses a structured layout to present the company's oncology portfolio, categorizing drugs by their therapeutic focus and market position.AstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Rising SuccessLoop · Logic Chain1 hit
09
Includes specific drug names and market projections for 2028.AstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Rising SuccessLoop · Logic Chain1 hit
04
The slide uses a structured layout to present market data for three distinct cancer segments, including CAGR and projected market values.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Logic Chain1 hit
05
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Logic Chain1 hit
06
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Logic Chain1 hit
04
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
05
Uses a before-after-framing structure to position the company's solution against industry-wide challenges.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
06
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
07
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
08
The slide uses a hub-and-spoke diagram centered on 'Precision Medicine' with six surrounding functional modules.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
09
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
10
The slide uses a horizontal bar chart structure to represent clinical development stages.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
05
The slide uses a column-based layout to compare four distinct business segments.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations Beat · ProblemLoop · Logic Chain1 hit
06
The chart uses a trend line to emphasize the reduction in concentration.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations Loop · Logic Chain1 hit
19
The slide outlines the status of a partnership with Sanofi and clinical trial timelines.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
20
Includes clinical trial identifiers and definitions of acronyms in the footer.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit